Nanostructure-assisted ultrasound shows potential for Parkinson's treatment
Researchers have developed a method using hollow silica nanostructures combined with low-intensity ultrasound to treat Parkinson's disease in mice. This non-invasive approach aims to provide precise neuromodulation without the need for surgical electrode implantation.
Why it matters
This technology could offer a less invasive, more sustainable alternative to current deep brain stimulation surgeries for Parkinson's patients.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Characterization of the fabricated hollow silica nanostructures (HSN). Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-69710-8 Parkinson's disease (PD) is one of the most common neurological disorders associated with later life, and its prevalence rises sharply with age. It affects the brain systems that control movement, often causing tremor, stiffness, slowness and problems with balance, all of which can reduce independence and quality of life in older adults. The condition is mainly linked to the gradual loss of dopamine-producing nerve cells.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in